Latest arthritis Stories

ATLANTA, May 1, 2013 /PRNewswire-USNewswire/ -- The Arthritis Foundation is announcing a new multiyear public awareness campaign in conjunction with Arthritis Month this May to debunk the myths of arthritis. The Faces of Arthritis campaign will feature public service ads focusing on the harsh realities of arthritis and dispelling the common stereotypes often associated with the disease. (Photo: http://photos.prnewswire.com/prnh/20130501/DC04740) As the nation's leading cause of...

A gas associated with the smell of rotten eggs has proven to effectively reduce joint swelling, in research which could lead to advances in the treatment of arthritis. Scientists at the University of Exeter Medical School have discovered that a novel drug molecule, which slowly generates the gas hydrogen sulfide (H2S), effectively reduces swelling and inflammation in arthritic joints. For years, H2S has been regarded as a highly poisonous by-product which is corrosive, flammable and...

SCOTTSDALE, Ariz., April 29, 2013 /PRNewswire/ -- Massage Envy, the pioneer and national leader of professional, convenient and affordable massage and spa services, in conjunction with the Touch Research Institute at the University of Miami School of Medicine, announced today the results of a new study that concludes moderate pressure massage therapy can decrease pain for rheumatoid arthritis patients. (Logo: http://photos.prnewswire.com/prnh/20130429/NY03571LOGO ) Additionally,...

New magnetic necklace for headaches and arthritis pain relief announced by Superior Magnetics for Pain Free Living Boston, Massachusetts (PRWEB) April 27, 2013 Pain Free Living - SuperiorMagnetics.com an innovative leader in developing alternative pain relief products announced a new magnetic necklace for pain relief. This new magnetic necklace for headaches and arthritis uses the 5000 Gauss neodymium rare earth magnets. Customers are reporting pain relief for headaches and arthritis in...

GREENWOOD VILLAGE, Colo., April 25, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) today announced the completion of patient enrollment in a dose-escalation run-in study to a Phase III pivotal trial evaluating Ampion in the treatment of moderate to severe osteoarthritis of the knee. Twelve week primary endpoint data are expected in the third quarter of 2013. (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) In the SPRING trial, Ampion is being...

Magnetic bracelet for pain relief in seconds for arthritis, tendinitis and bursitis, announced Superior Magnetics for Pain Free Living. Charleston, SC (PRWEB) April 24, 2013 Pain Free Living - SuperiorMagnetics.com an innovator in alternative pain relief products, announced a magnetic bracelet so strong it relieves pain in seconds. The free demonstration of pain relief with their magnetic bracelet for arthritis is performed at fairs and festivals. This magnetic health bracelet for...

Researchers report in Nature Genetics they have increased the number of confirmed genes linked to juvenile idiopathic arthritis (JIA) from three to 17 – a finding that will clarify how JIA fits into the spectrum of autoimmune disorders and help identify potential treatment targets. Published April 21, the study involves an international research team that analyzed 2,816 JIA cases recruited from more than 40 pediatric rheumatology clinics. It was the largest collaborative patient...

CINCINNATI, April 24, 2013 /PRNewswire-USNewswire/ -- Researchers report in Nature Genetics they have increased the number of confirmed genes linked to juvenile idiopathic arthritis (JIA) from three to 17 - a finding that will clarify how JIA fits into the spectrum of autoimmune disorders and help identify potential treatment targets. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Published April 21, the study involves an international research team that analyzed...

NORWALK, Conn., April 24, 2013 /PRNewswire/ -- UBM Medica US announces that Musculoskeletal Network features exclusive coverage of the Osteoarthritis Research Society International (OARSI), concluded on Sunday, April 21, in Philadelphia. OARSI is the premier international organization for scientists and health care professionals focused on the prevention and treatment of osteoarthritis (OA). The latest reports from the world's top researchers in osteoarthritis include new support...

Surveyed US Rheumatologists Believe Actemra is Most at Risk for Displacement by Xeljanz, According to a New Report from BioTrends Research Group EXTON, Pa., April 24 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that two-thirds of surveyed U.S. rheumatologists believe that--at three months post launch--initiations of Pfizer's Xeljanz in the rheumatoid arthritis (RA) treatment...